{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:50:44Z","timestamp":1760622644353},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T00:00:00Z","timestamp":1210032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11060-008-9603-8","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T14:35:48Z","timestamp":1209998148000},"page":"187-193","source":"Crossref","is-referenced-by-count":11,"title":["A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis"],"prefix":"10.1007","volume":"89","author":[{"given":"Nimish A.","family":"Mohile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Raizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Paleologos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Kewalramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Gregory","family":"Cairncross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren E.","family":"Abrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"9603_CR1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.1994.12.10.2013","volume":"12","author":"G Cairncross","year":"1994","unstructured":"Cairncross G, Macdonald D, Ludwin S et al (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013\u20132021","journal-title":"J Clin Oncol"},{"key":"9603_CR2","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","volume":"24","author":"G Cairncross","year":"2006","unstructured":"Cairncross G, Berkey B, Shaw E et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707\u20132714","journal-title":"J Clin Oncol"},{"key":"9603_CR3","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"MJ Bent van den","year":"2006","unstructured":"van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715\u20132722","journal-title":"J Clin Oncol"},{"key":"9603_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1200\/JCO.1994.12.3.627","volume":"12","author":"JR Crossen","year":"1994","unstructured":"Crossen JR, Garwood D, Glatstein E, Neuwelt EA (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12:627\u2013642","journal-title":"J Clin Oncol"},{"key":"9603_CR5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/WNL.53.5.1141","volume":"53","author":"NA Paleologos","year":"1999","unstructured":"Paleologos NA, Macdonald DR, Vick NA, Cairncross JG (1999) Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology 53:1141\u20131143","journal-title":"Neurology"},{"key":"9603_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/B:NEON.0000003645.82791.2a","volume":"65","author":"LE Abrey","year":"2003","unstructured":"Abrey LE, Childs BH, Paleologos N et al (2003) High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J Neurooncol 65:127\u2013134","journal-title":"J Neurooncol"},{"key":"9603_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1215\/15228517-2005-009","volume":"8","author":"LE Abrey","year":"2006","unstructured":"Abrey LE, Childs BH, Paleologos N et al (2006) High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol 8:183\u2013188","journal-title":"Neuro Oncol"},{"key":"9603_CR8","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) World Health Organization International Agency for Research on Cancer."},{"key":"9603_CR9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"issue":"10","key":"9603_CR10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"key":"9603_CR11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1215\/15228517-2007-002","volume":"9","author":"LE Abrey","year":"2007","unstructured":"Abrey LE, Louis DN, Paleologos N et al (2007) Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro-Oncol 9:314\u2013318","journal-title":"Neuro-Oncol"},{"issue":"10","key":"9603_CR12","first-page":"3599","volume":"92","author":"E Careras","year":"1998","unstructured":"Careras E, Bertz H, Arcese W et al (1998) Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood 92(10):3599\u20133604","journal-title":"Blood"},{"key":"9603_CR13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cncr.22761","volume":"110","author":"V Ridola","year":"2007","unstructured":"Ridola V, Grill J, Doz F et al (2007) High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence of progression after conventional chemotherapy. Cancer 110:156\u2013163","journal-title":"Cancer"},{"issue":"20","key":"9603_CR14","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","volume":"66","author":"RB Jenkins","year":"2006","unstructured":"Jenkins RB, Blair H, Ballman KV et al (2006) a t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66(20):9852\u20139861","journal-title":"Cancer Res"},{"key":"9603_CR15","first-page":"839","volume":"7","author":"Y Ino","year":"2001","unstructured":"Ino Y, Betensky RA, Zlatescu MC et al (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839\u2013845","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-008-9603-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9603-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:19:20Z","timestamp":1559362760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9603-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,6]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9603"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9603-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,6]]}}}